Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay
Jianhui Nie, Qianqian Li, Jiajing Wu, et al.
Nature Protocols (2020) Vol. 15, Iss. 11, pp. 3699-3715
Open Access | Times Cited: 383

Showing 1-25 of 383 citing articles:

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 541
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Qianqian Li, Jianhui Nie, Jiajing Wu, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2362-2371.e9
Open Access | Times Cited: 381
Diagnostics for COVID-19: moving from pandemic response to control
Rosanna W. Peeling, Dominique Heymann, Yik-Ying Teo, et al.
The Lancet (2021) Vol. 399, Iss. 10326, pp. 757-768
Open Access | Times Cited: 381
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
Li Zhang, Qianqian Li, Ziteng Liang, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 1-5
Open Access | Times Cited: 371
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
Jingwen Ai, Haocheng Zhang, Yi Zhang, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 337-343
Open Access | Times Cited: 357
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays
Kevin R. Bewley, Naomi S. Coombes, Luc Gagnon, et al.
Nature Protocols (2021) Vol. 16, Iss. 6, pp. 3114-3140
Open Access | Times Cited: 269
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 214
COVID‐19 vaccinations: The unknowns, challenges, and hopes
Kawthar Mohamed, Piotr Rzymski, Md Shahidul Islam, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1336-1349
Open Access | Times Cited: 119
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
Jean‐Louis Bayart, Jonathan Douxfils, Constant Gillot, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1092-1092
Open Access | Times Cited: 113
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
Qing Xiong, Lei Cao, Chengbao Ma, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 748-757
Open Access | Times Cited: 100
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
Philip L. Tzou, Kaiming Tao, Sergei L. Kosakovsky Pond, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0261045-e0261045
Open Access | Times Cited: 93
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
Lianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 3, pp. 342-351
Open Access | Times Cited: 75
Enhanced transmissibility of XBB.1.5 is contributed by both strong ACE2 binding and antibody evasion
Can Yue, Weiliang Song, Lei Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 74
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu, Jie Zhou, Wei Xu, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 269-287
Open Access | Times Cited: 71
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2
Liangxia Ai, Yafei Li, Li Zhou, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 51
Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery
Liang Leng, Zhichao Xu, Bixia Hong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion
Song Xue, Yuru Han, Fan Wu, et al.
Protein & Cell (2024) Vol. 15, Iss. 6, pp. 403-418
Open Access | Times Cited: 18
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins
Weiwei Li, Zepeng Xu, Tianhui Niu, et al.
The EMBO Journal (2024) Vol. 43, Iss. 8, pp. 1484-1498
Open Access | Times Cited: 16
Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses
Chengbao Ma, Chen Liu, Young‐Jun Park, et al.
Cell (2025)
Open Access | Times Cited: 3
Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
Marta Alenquer, Filipe Ferreira, Diana Lousa, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 8, pp. e1009772-e1009772
Open Access | Times Cited: 93
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
Haya Altawalah
Vaccines (2021) Vol. 9, Iss. 8, pp. 910-910
Open Access | Times Cited: 69
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang, Ying Lu, Yan‐Bo Zhao, et al.
Cell Research (2022) Vol. 32, Iss. 12, pp. 1068-1085
Open Access | Times Cited: 51
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Zhenhao Fang, Lei Peng, Renata B. Filler, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top